Ignite Creation Date:
2024-05-05 @ 4:42 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00299520
Status:
COMPLETED
Last Update Posted:
2008-04-04
First Post:
2006-03-03
Brief Title:
Phase 3 Safety and Efficacy Study of IV Iclaprim v Linezolid in cSSSI ASSIST-1
Sponsor:
Arpida AG
Organization:
Arpida AG
Organization Data
Organization:
Arpida AG
Class:
INDUSTRY
Study ID:
Protocol No ICLA-08-CSI1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Arpida AG
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None